DEBORAH KINNEY: Open Payments
NPI 1124027255 · EVANSVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$288 in 17 payments from 9 companies in 2025. Trend: 2023 $413 · 2024 $255 · 2025 $288
Food & beverage: $288
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $58 |
| GlaxoSmithKline, LLC. | 3 | $57 |
| ABBVIE INC. | 3 | $55 |
| PFIZER INC. | 2 | $41 |
| Viatris Specialty LLC | 1 | $23 |
| Exact Sciences Corporation | 1 | $15 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
| Phathom Pharmaceuticals, Inc. | 1 | $9 |
Products named: Ozempic, SHINGRIX, QULIPTA, NURTEC ODT, YUPELRI, AREXVY, UBRELVY, PREVNAR 20.
Industry payments across IN — which companies pay providers there.
